Targeting Tumor Amino Acid Addiction Exposes Vulnerabilities and Therapeutic Hurdles
A comprehensive review explores how therapeutically targeting four critical amino acid metabolic axes can induce cancer cell death while confronting ...
Tag: Synthetic lethality
Yeast PRS Gene Products Coordinate Nucleotide Precursor Synthesis and Cell Wall Integrity
Evidence from genetic, biochemical, and database analyses reveals that Saccharomyces cerevisiae Prs gene products form multifunctional heterodimers that simultaneously synthesize ...
Selective TNKS2 Inhibitor Targets Common Vulnerability in WNT-Driven Cancer Cells
Researchers have identified a selective inhibitor targeting the TNKS2 enzyme in cancers missing TNKS1, offering a potential strategy to block ...
Clustered Mutations in Knowledge Graphs Improve Cold-Start Drug-Target Interaction Predictions
Researchers incorporated clustered somatic mutations into a knowledge graph embedding framework to enhance the computational prediction of drug-target interactions for ...
Review Outlines How Oxidative Stress and DNA Damage Expose Cancer Vulnerabilities
A scientific review highlights how oxidative stress drives cancer progression while exposing therapeutic vulnerabilities that can be targeted through synthetic ...
Cas12a Screens Map Genetic Architecture Across the DNA Damage Response Network
Unbiased Cas12a combinatorial knockout screens across 233 genes have mapped synthetic lethal and buffering interactions across the DNA damage response ...
Replication Fork Instability at Specific Loci Drives PARP Inhibitor Cytotoxicity in Cells
A cell study reveals that loss of the cohesin acetyltransferase ESCO2 promotes G-quadruplex accumulation at pericentromeric regions, driving replication fork ...
Eye Cancer’s Hidden Weakness: CRISPR Screens Expose p300 as a Lifeline for GNAQ-Mutant Tumors
CRISPR-based synthetic lethal screening has identified the acetyltransferases p300 and CBP as essential chromatin partners for YAP-driven transcription in GNAQ-mutant ...
ATR Inhibitor Ceralasertib Paired With Olaparib Shows Promise in BRCA-Mutant Breast Cancer
A Phase 1 trial found that combining the ATR inhibitor ceralasertib with the PARP inhibitor olaparib was generally well tolerated ...
Targeting Thymine Glycosylase Kills p53-Deficient Cancer Cells
In a groundbreaking study, researchers have unveiled the intricate role of thymine DNA glycosylase (TDG) in the realm of cancer ...
POPULAR NEWS
-
Exercise Training Regulates Mitochondrial Dynamic Proteins in Visceral Fat of Diabetic Rats
-
Bacterial Consortium Enhances Antioxidant Levels and Crop Yield in Black Rice
-
Urinary Multi-Omics Panel Enables Non-Invasive Detection of Clear Cell Kidney Cancer
-
Integrated Local Oscillator and Active Phase Stabilization Improve Heterodyne CARS Imaging Contrast